"A Single infusion of CCR5 modified stem-like CD4 T cells provide SIV control upon ATI"

Dr. Mojahidul Islam is a Postdoctoral Fellow at Emory University in the Pathology and Advanced Translational Research Unit (PATRU), mentored by Dr. Ashish Sharma. He earned his Ph.D. in Biomedical Sciences (Immunology) from the Institute of Liver and Biliary Sciences in New Delhi, India, where his research focused on immune and epigenetic mechanisms regulating hepatitis B virus reactivation and clearance.

At Emory, Dr. Islam’s research centers on advancing next-generation cell therapies for HIV cure. He engineers CCR5-modified stem-like CD4 T cells with enhanced antiviral function, persistence, and resistance to infection. As part of the NIH-funded RID-HIV consortium, he integrates single-cell transcriptomics, immune profiling, and non-human primate models to evaluate the efficacy of these cells in controlling SIV after analytical treatment interruption (ATI). His broader interests span immune reprogramming, T cell stemness and exhaustion, systems immunology, and translational virology.

Dr. Islam has received several national and international honors and has recently presented his work at leading conferences, including CROI 2025 and AAI IMMUNOLOGY 2025.